245 related articles for article (PubMed ID: 9443937)
1. The involvement of novel protein kinase C isozymes in influencing sensitivity of breast cancer MCF-7 cells to tumor necrosis factor-alpha.
Basu A
Mol Pharmacol; 1998 Jan; 53(1):105-11. PubMed ID: 9443937
[TBL] [Abstract][Full Text] [Related]
2. Differential sensitivity of breast cancer cells to tumor necrosis factor-alpha: involvement of protein kinase C.
Basu A; Mohanty S; Sun B
Biochem Biophys Res Commun; 2001 Jan; 280(3):883-91. PubMed ID: 11162606
[TBL] [Abstract][Full Text] [Related]
3. Phorbol ester-enhanced noradrenaline secretion correlates with the presence and activity of protein kinase C-alpha in human SH-SY5Y neuroblastoma cells.
Turner NA; Walker JH; Ball SG; Vaughan PF
J Neurochem; 1996 Jun; 66(6):2381-9. PubMed ID: 8632160
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells.
Basu A; Weixel K; Saijo N
Cell Growth Differ; 1996 Nov; 7(11):1507-12. PubMed ID: 8930400
[TBL] [Abstract][Full Text] [Related]
5. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
Szallasi Z; Denning MF; Smith CB; Dlugosz AA; Yuspa SH; Pettit GR; Blumberg PM
Mol Pharmacol; 1994 Nov; 46(5):840-50. PubMed ID: 7969070
[TBL] [Abstract][Full Text] [Related]
6. Regulation of epithelial transport and barrier function by distinct protein kinase C isoforms.
Song JC; Hanson CM; Tsai V; Farokhzad OC; Lotz M; Matthews JB
Am J Physiol Cell Physiol; 2001 Aug; 281(2):C649-61. PubMed ID: 11443064
[TBL] [Abstract][Full Text] [Related]
7. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells.
Stanwell C; Gescher A; Bradshaw TD; Pettit GR
Int J Cancer; 1994 Feb; 56(4):585-92. PubMed ID: 8112895
[TBL] [Abstract][Full Text] [Related]
8. Bryostatin-1 attenuates TNF-induced epithelial barrier dysfunction: role of novel PKC isozymes.
Yoo J; Nichols A; Song JC; Mammen J; Calvo I; Worrell RT; Cuppoletti J; Matlin K; Matthews JB
Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G703-12. PubMed ID: 12505880
[TBL] [Abstract][Full Text] [Related]
9. Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms.
Wang S; Wang Z; Grant S
Mol Pharmacol; 2003 Jan; 63(1):232-42. PubMed ID: 12488556
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C activation modulates pro- and anti-apoptotic signaling pathways.
Meinhardt G; Roth J; Totok G
Eur J Cell Biol; 2000 Nov; 79(11):824-33. PubMed ID: 11139146
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of cisplatin sensitivity of cisplatin-resistant human cervical carcinoma cells by bryostatin 1.
Mohanty S; Huang J; Basu A
Clin Cancer Res; 2005 Sep; 11(18):6730-7. PubMed ID: 16166454
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of protein kinase C-eta attenuates caspase activation and tumor necrosis factor-alpha-induced cell death.
Akkaraju GR; Basu A
Biochem Biophys Res Commun; 2000 Dec; 279(1):103-7. PubMed ID: 11112424
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
Kennedy MJ; Prestigiacomo LJ; Tyler G; May WS; Davidson NE
Cancer Res; 1992 Mar; 52(5):1278-83. PubMed ID: 1737390
[TBL] [Abstract][Full Text] [Related]
14. Expression and phorbol ester-induced down-regulation of protein kinase C isozymes in osteoblasts.
Sanders JL; Stern PH
J Bone Miner Res; 1996 Dec; 11(12):1862-72. PubMed ID: 8970887
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of interleukin-6 promoter by parathyroid hormone, tumor necrosis factor alpha, and interleukin-1beta in UMR-106 osteoblastic cells is inhibited by protein kinase C antagonists.
Nagy Z; Radeff J; Stern PH
J Bone Miner Res; 2001 Jul; 16(7):1220-7. PubMed ID: 11450697
[TBL] [Abstract][Full Text] [Related]
16. Activation of protein kinase C subtypes alpha, gamma, delta, epsilon, zeta, and eta by tumor-promoting and nontumor-promoting agents.
Geiges D; Meyer T; Marte B; Vanek M; Weissgerber G; Stabel S; Pfeilschifter J; Fabbro D; Huwiler A
Biochem Pharmacol; 1997 Mar; 53(6):865-75. PubMed ID: 9113106
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts.
Szallasi Z; Smith CB; Pettit GR; Blumberg PM
J Biol Chem; 1994 Jan; 269(3):2118-24. PubMed ID: 8294465
[TBL] [Abstract][Full Text] [Related]
18. Specific protein kinase C isozymes mediate the induction of keratinocyte differentiation markers by calcium.
Denning MF; Dlugosz AA; Williams EK; Szallasi Z; Blumberg PM; Yuspa SH
Cell Growth Differ; 1995 Feb; 6(2):149-57. PubMed ID: 7756173
[TBL] [Abstract][Full Text] [Related]
19. Role of specific protein kinase C isozymes in mediating epidermal growth factor, thyrotropin-releasing hormone, and phorbol ester regulation of the rat prolactin promoter in GH4/GH4C1 pituitary cells.
Pickett CA; Manning N; Akita Y; Gutierrez-Hartmann A
Mol Endocrinol; 2002 Dec; 16(12):2840-52. PubMed ID: 12456804
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different tumour promoters and bryostatin 1 on protein kinase C activation and down-regulation in rat renal mesangial cells.
Huwiler A; Fabbro D; Pfeilschifter J
Biochem Pharmacol; 1994 Aug; 48(4):689-700. PubMed ID: 8080441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
